Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Learn about Alcon’s transformation journey
to unify operations, optimise data environments, and re-establish Alcon as a
medical device company after the divestiture from Novartis. From replacing the
inefficient multi-vendor mix of applications to reimagining the way Alcon
works, the task ahead was enormous.
Now, at the end of the two year journey, Dr. Ken Sullivan, VP and Global Head of Clinical R&D at Alcon, shares the experience, challenges, and key principles the company followed to unify clinical operations and data, including:
VP and Global Head, Clinical R&D
Alcon LLC
Nearly 30 years’ experience in clinical trials and statistical sciences across all phases of product development in industry, academia, and NIH settings. Currently leads Alcon’s Clinical R&D team responsible for the strategic and operational design, execution, and reporting of all Alcon clinical development activities and all global medical affairs brand plans for Alcon’s pipeline and existing marketed portfolio of products.
Senior Director, Strategy
Veeva MedTech
By completing this form you agree Veeva Systems Inc. may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy.
